Clinical Trial Update: A Clinical Research of CAR T Cells Targeting CEA Positive Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CAR T cells targeting CEA-positive cancers across multiple solid tumor indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• CEA-targeted CAR T cells (Chimeric antigen receptor T cells targeting carcinoembryonic antigen (CEA))

Snippet

Sponsor: Southwest Hospital, China | Conditions: Lung Cancer, Colorectal Cancer | Phase 1 | Status: UNKNOWN